Predicta Biosciences
predictabiosciences.com
Actively hiring
Precision Medicine
Molecular Diagnostics
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Predicta Biosciences and CIMA LAB Diagnostics Announce Agreement to Advance Ultrasensitive Blood-Based Diagnostics for Multiple Myeloma and Other Hematological Malignancies
CAMBRIDGE, Mass. & PAMPLONA, Spain-(BUSINESS WIRE)-Predicta Biosciences, a company building ultra-sensitive molecular and immune diagnostic platforms, and CIMA LAB Diagnostics from the Clínica Universidad de Navarra, a leading European University Medical
Read more
Report
Predicta Biosciences and CIMA LAB Diagnostics Announce Agreement to Advance Ultrasensitive Blood-Based Diagnostics for Multiple Myeloma and Other Hematological Malignancies
CAMBRIDGE, Mass. & PAMPLONA, Spain, June 10, 2026--Predicta Biosciences, a company building ultra-sensitive molecular and immune diagnostic platforms, and CIMA LAB Diagnostics from the Clínica Universidad de Navarra, a leading European University Medical
Read more
Report
Predicta Biosciences and CIMA LAB Diagnostics Announce Agreement to Advance Ultrasensitive Blood-Based Diagnostics for Multiple Myeloma and Other Hematological Malignancies
Predicta Biosciences, a company building ultra-sensitive molecular and immune diagnostic platforms, and CIMA LAB Diagnostics from the Clínica Universidad de Navarra, a leading European University Medical
Read more
Report
Predicta Biosciences and CIMA LAB Diagnostics Announce Agreement to Advance Ultrasensitive Blood-Based Diagnostics for Multiple Myeloma and Other Hematological Malignancies
Read more
Report
Predicta Biosciences Appoints Dr. Craig L. Tendler as Independent Director to its Board
CAMBRIDGE, Mass.-(BUSINESS WIRE)-Predicta Biosciences, a company building ultra-sensitive molecular and immune diagnostic platforms, today announced the appointment of Craig L. Tendler, M.D., as an independent director to its Board of Directors. Dr. Tendl
Read more
Report
Predicta Biosciences Appoints Dr. Craig L. Tendler as Independent Director to its Board - AOL
Read more
Report
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
CHICAGO-(BUSINESS WIRE)-Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Predicta Biosciences, a precision oncology company developing novel diagnostic solutions for deep molecular character
Read more
Report
Predicta Biosciences: $23.4 Million Series A Raised To Advance Diagnostic And Therapeutic Discovery Tools
Predicta Biosciences, a precision oncology company focused on developing advanced diagnostic and therapeutic discovery tools, has announced the close of a $23.4 million Series A funding round. The funding round was oversubscribed and led by Engine Venture
Read more
Report
Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases
CAMBRIDGE, Mass., October 01, 2025-(BUSINESS WIRE)-Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubscribed $23.4 million Series A led by Engine Ven
Read more
Report
Show more news
Salary insights
Compensation ranges based on this company's open jobs
Median
$95k
Typical range
$95k
Open positions
1
1
Jobs
Junior
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 1 | $95k | $95k |
Highest paying role
Client Services Specialist
$95k
Normalized to USD per year
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Customer Success
100% ▲